Healthtech Startups

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells. The company partners with pharmaceutical firms to advance development of novel therapeutic modalities.

2 investors

Cayuga Biotech is a clinical-stage biotechnology company developing therapeutics for hemorrhage and blood-clotting-related conditions, with a lead candidate CAY001. It focuses on the hemostasis and thrombosis space, drawing on materials chemistry and translational medicine.

2 investors

CDL Nuclear Technologies designs and supplies cardiac PET/CT imaging equipment and services for medical facilities. The company offers flexible deployment options including custom suites, mobile units, and trailers to help cardiology practices adopt advanced diagnostic imaging technology.

2 investors

Cedargate provides a unified software platform for healthcare organizations transitioning to value-based care models, with integrated data management, analytics, decision support, and claims processing tools. The platform helps providers measure outcomes, reduce costs, and coordinate care delivery across multiple payer and patient populations.

2 investors

Cedience provides a SaaS platform that uses natural language processing and machine learning to help drug development teams quickly find evidence-backed answers to regulatory questions by centralizing and integrating regulatory databases. The platform serves pharmaceutical and biotech companies navigating drug development and regulatory approval processes.

2 investors

Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities. The company applies this technology to stem cell transplantation and gene therapy for blood cancers such as leukemia and other blood and genetic diseases.

2 investors

Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers. Its lead candidate, gedatolisib, targets all Class I PI3K isoforms and the mTORC1 and mTORC2 complexes and is being evaluated across multiple oncology clinical programs.

2 investors

Xcelthera develops cell therapy platform technology, serving the biotech and therapeutic development sector.

2 investors

A software platform for home health, hospice, and personal care agencies that integrates documentation, scheduling, and billing workflows to improve care delivery and operational efficiency.

2 investors

cellvie develops Therapeutic Mitochondria Transplantation technology and products for patients requiring mitochondrial treatment. The company combines expertise across science, regulatory affairs, manufacturing, and business to advance this therapeutic platform.

2 investors

Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine. Acquired by AbbVie Inc. in June 2024.

2 investors

Celsus develops artificial intelligence software for analyzing medical imaging, specifically mammograms and chest X-rays, to help radiologists detect diseases and pathologies. The solution serves healthcare providers and radiologists seeking to improve diagnostic accuracy.

2 investors

Celularity is a regenerative and cellular medicine company developing and commercializing biomaterial products and allogeneic, cryopreserved cell therapies derived from the postpartum placenta to target age-related diseases. It operates its own integrated manufacturing, translational research, and biobanking facility for placenta-derived cellular medicines and advanced biomaterials.

2 investors

Cenacle builds a digital healthcare platform that connects hospitals and individuals, offering a cloud SaaS EMR for hospitals and a tethered PHR service for patients to access and use their own and family medical and health records. The platform aims to link healthcare partners into a connected medical ecosystem.

2 investors

CenExel operates a network of clinical research centers that conduct trials and studies to advance new medical treatments. The company serves pharmaceutical sponsors, biotech firms, and patients by providing clinical research infrastructure and expertise across 18 sites in the United States.

2 investors

Centauri Health Solutions provides technology platforms that turn fragmented clinical and member data into coordinated actions for U.S. health plans and health systems, covering benefit eligibility, enrollment and retention, risk adjustment, quality optimization, and care coordination. It serves Medicaid Managed Care Plans, Medicare Advantage Plans, hospitals, and healthcare providers.

2 investors

Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets. The platform is intended for treatment of life-threatening indications across multiple disease areas.

2 investors

Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.

2 investors

CenTrak provides Real-Time Location System (RTLS) technology for healthcare facilities, including IoT wearables, infrastructure devices, software, and integrations with systems like EMR, CMMS, and Nurse Call. Its solutions cover asset tracking, patient and staff safety, workflow, environmental monitoring, and patient experience across hospitals and health systems.

2 investors

Cephable builds cross-platform desktop and mobile software plus a developer SDK that lets people control digital tools through voice, face, head, and button-based input, with on-device generative AI for tasks like content creation and translation. It is used by individuals, teams, students, educators, developers, and enterprises for accessible and adaptive productivity across any software.

2 investors

Cepheid manufactures molecular diagnostic instruments and tests that automate PCR-based testing for infectious diseases, oncology, and human genetics. The company serves institutions ranging from central laboratories to near-patient settings with automated diagnostic solutions.

2 investors

Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders. The company brings together expertise in neuroscience, engineering, and medical devices to advance non-invasive neuromodulation solutions.

2 investors

Certainly is an aesthetics and wellness concierge service that provides price transparency and personalized guidance for cosmetic and medical treatments. It connects patients with vetted providers to help them access care at better prices while meeting their appearance and wellness goals.

2 investors

Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance. It serves pharma and biotech teams developing KRAS-directed cancer therapies for NSCLC, pancreatic (PDAC), and colorectal cancers, providing benchmarking, biomarker, and combination-strategy evidence.

2 investors